Related Experiment Video
Updated: Aug 20, 2026

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
Published on: January 6, 2015
Markers of impaired growth of pulmonary function in children and adolescents
1Department of Clinical Physiology and Nuclear Medicine KF, Rigshospitalet, and Department of Internal Medicine I, Pulmonary Unit, Bispebjerg Hospital, Copenhagen, Denmark.
Insights
Asthma, airway hyperresponsiveness, and house dust mite (HDM) allergy negatively impact lung function growth in children. Even without asthma, HDM sensitization impairs FEV1 growth, highlighting allergy
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Respiratory Medicine
Background:
- Pulmonary function growth in children is not fully understood.
- Factors influencing lung function development require further investigation.
Purpose of the Study:
- To investigate the relationship between various factors and pulmonary function growth in children and adolescents.
- To identify predictors of lung function trajectories in pediatric populations.
Main Methods:
- Longitudinal study of 408 children (7-17 years) over 6 years.
- Assessment of pulmonary function (FEV1), allergen reactivity, and airway responsiveness (AR).
- Definition of airway hyperresponsiveness (AHR) based on histamine challenge.
Main Results:
- Asthma, atopy to house dust mite (HDM), and increasing AR were linked to lower FEV1 %pred cross-sectionally.
- Longitudinally, asthma and lower baseline FEV1 predicted reduced FEV1 at follow-up.
- Increased AR, new asthma, and new HDM atopy predicted lower FEV1, even in non-asthmatic subjects without AHR.
Conclusions:
- Pulmonary function growth in children is negatively affected by asthma, increasing airway responsiveness, and HDM atopy.
- HDM sensitization impacts FEV1 growth, irrespective of asthma or AHR status.
- Early identification and management of HDM allergy may be crucial for optimal lung development.
Abstract:
Our knowledge about the age-related growth of pulmonary function is incomplete. The purpose of this study was to describe the relation of various factors to the growth of pulmonary function in children and adolescents. A population sample comprising 408 children and adolescents (7-17 yr of age at enrollment) was reexamined after a 6-yr interval. Case history was obtained by interview and questionnaire. Pulmonary function, skin prick test reactivity to common allergens, and airway responsiveness (AR) were measured using standard techniques; airway hyperresponsiveness (AHR) was defined as a concentration of histamine causing a 20% decline in FEV1 < 8 mg/ml. The cross-sectional analyses of data from the two surveys showed that the presence of asthma (p < 0.02), atopy to house dust mite (HDM) (p = 0.03), and increasing degree of AR (p < 0.002) were associated with a lower level of FEV1 %pred. The longitudinal analysis revealed that asthma (p = 0.0001) and a lower level of FEV1 (p < 0.0001) at enrollment were associated with a lower level of FEV1 at follow-up. Further, an increase in the degree of AR (p = 0. 0001), new asthma (p = 0.0002), and new atopy to HDM (p = 0.03) also predicted a lower level of FEV1 at the end of the observation period. Confining the analysis to subjects without asthma and without evidence of AHR (n = 271) showed that both persistent (p = 0.04) and new (p = 0.03) atopy to HDM predicted a lower level of FEV1 at follow-up; compared with subjects with a negative skin reaction to HDM, those subjects who were sensitized to HDM had on average a 5%pred lower level of FEV1. The growth of FEV1 in children and adolescents appears to be impaired not only by symptomatic asthma but also by an increase in the degree of AR and atopy to HDM; sensitization to HDM appears to have a negative impact on the age-related growth in FEV1 even in nonasthmatic subjects without evidence of AHR.
Related Concept Videos
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration can...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

